Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

videos

John Allan, MD
Videos
Analyzing the Role of BTK Inhibitors and Combination Therapies in the Frontline Treatment of Patients With CLL
08/18/2023

Featuring John Allan, MD

Featuring John Allan, MD
At the 2023 Great Debates & Updates in Hematologic Malignancies Meeting, John Allan, MD, analyzes the role of BTK inhibitors and combination therapies in the frontline treatment of patients with chronic lymphocytic leukemia.
At the 2023 Great Debates & Updates in Hematologic Malignancies Meeting, John Allan, MD, analyzes the role of BTK inhibitors and combination therapies in the frontline treatment of patients with chronic lymphocytic leukemia.
At the 2023 Great Debates &...
08/18/2023
Oncology
Carla Casulo, MD
Videos
Choosing Treatment Options and Managing Toxicities for Patients With R/R Follicular Lymphoma
08/18/2023

Featuring Carla Casulo, MD

Featuring Carla Casulo, MD
At the 2023 Great Debates & Updates in Hematologic Malignancies meeting, Carla Casulo, MD, summarizes the available treatment options for relapsed/refractory follicular lymphoma and options for managing various treatment-related toxicities.
At the 2023 Great Debates & Updates in Hematologic Malignancies meeting, Carla Casulo, MD, summarizes the available treatment options for relapsed/refractory follicular lymphoma and options for managing various treatment-related toxicities.
At the 2023 Great Debates &...
08/18/2023
Oncology
Elizabeth Brem, MD
Videos
Individualized Treatment Approaches for Patients With Hodgkin Lymphoma
08/18/2023

Featuring Elizabeth Brem, MD

Featuring Elizabeth Brem, MD
At the 2023 Great Debates & Updates in Hematologic Malignancies Meeting, Elizabeth Brem, MD, provides insights into treatment approaches used for cases of patients with Hodgkin lymphoma.
At the 2023 Great Debates & Updates in Hematologic Malignancies Meeting, Elizabeth Brem, MD, provides insights into treatment approaches used for cases of patients with Hodgkin lymphoma.
At the 2023 Great Debates &...
08/18/2023
Oncology
C. Ola Landgren, MD
Videos
Should ASCT be Standard of Care for Frontline Treatment of Patients With Multiple Myeloma?
05/15/2023
C. Ola Landgren, MD, PhD, participated in a debate on whether melphalan plus ASCT after induction therapy should continue to be the standard of care in frontline treatment of patients with multiple myeloma.
C. Ola Landgren, MD, PhD, participated in a debate on whether melphalan plus ASCT after induction therapy should continue to be the standard of care in frontline treatment of patients with multiple myeloma.
C. Ola Landgren, MD, PhD,...
05/15/2023
Oncology
Amrita Krishnan, MD
Videos
ASCT as the Continued Standard of Care in Frontline Multiple Myeloma Therapy
05/10/2023
Amrita Krishnan, MD, participated in a debate about whether high-dose chemotherapy followed by autologous stem cell transplant after completion of induction therapy is the optimal frontline therapy for patients with multiple myeloma.
Amrita Krishnan, MD, participated in a debate about whether high-dose chemotherapy followed by autologous stem cell transplant after completion of induction therapy is the optimal frontline therapy for patients with multiple myeloma.
Amrita Krishnan, MD,...
05/10/2023
Oncology
Michael Rosenzweig, MD
Videos
Strategies for Diagnosing and Treating Patients With Amyloidosis
05/10/2023
Michael Rosenzweig, MD, shares insights on strategies for diagnosing and treating patients with various subtypes of amyloidosis.
Michael Rosenzweig, MD, shares insights on strategies for diagnosing and treating patients with various subtypes of amyloidosis.
Michael Rosenzweig, MD, shares...
05/10/2023
Oncology
Matthew Matasar MD
Videos
Increasing Quality of Life Using Survivorship-Focused Care for Patients With Hodgkin and Non-Hodgkin Lymphoma
05/05/2023
At the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, New York, Matthew Matasar, MD, discussed the importance of utilizing survivorship-focused care models and increasing the quality of life of lymphoma...
At the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, New York, Matthew Matasar, MD, discussed the importance of utilizing survivorship-focused care models and increasing the quality of life of lymphoma...
At the 2023 Great Debates &...
05/05/2023
Oncology
John Mascarenhas, MD
Videos
Recent Advancements in Clinical Development for the Treatment of Myelofibrosis
05/04/2023
At the 2023 Great Debates & Updates in Hematologic Malignancies conference, New York, John Mascarenhas, MD, discussed recent advancements in clinical developments for the treatment of myeloproliferative neoplasms, specifically myelofibrosis,...
At the 2023 Great Debates & Updates in Hematologic Malignancies conference, New York, John Mascarenhas, MD, discussed recent advancements in clinical developments for the treatment of myeloproliferative neoplasms, specifically myelofibrosis,...
At the 2023 Great Debates &...
05/04/2023
Oncology
Joshua Richter, MD
Videos
Optimization of Therapies for Older or More Frail Patients With Multiple Myeloma
05/04/2023
At the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, New York, Joshua Richter, MD, discussed the optimization of therapies for older and more frail patients with multiple myeloma.
At the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, New York, Joshua Richter, MD, discussed the optimization of therapies for older and more frail patients with multiple myeloma.
At the 2023 Great Debates &...
05/04/2023
Oncology
Adam Olszewski MD Brown University
Videos
Role of CNS Prophylaxis in Aggressive B-Cell Lymphoma Treatment
05/03/2023
Adam Olszewski, MD, debates that CNS prophylaxis has a valuable role in the treatment of aggressive B-cell lymphomas such as diffuse large B-cell lymphoma.
Adam Olszewski, MD, debates that CNS prophylaxis has a valuable role in the treatment of aggressive B-cell lymphomas such as diffuse large B-cell lymphoma.
Adam Olszewski, MD, debates that...
05/03/2023
Oncology

Advertisement

About

At Great Debates and Updates in Hematologic Malignancies, nationally recognized thought leaders take opposing sides on clinical—and sometimes controversial—topics currently disrupting the practice of hematology and oncology.

Through comprehensive review of the latest clinical advancements in hematologic malignancies, robust audience engagement, and ample discussion, participants will leave equipped with practical implications and applications to put into practice immediately.

Platinum Sponsors

johnson & johnson

 

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use